EVE 0.00% 0.1¢ eve health group limited.

Agreed.!!..but the real problem here goes deeper in regard to...

  1. 1,527 Posts.
    lightbulb Created with Sketch. 41
    Agreed.!!..but the real problem here goes deeper in regard to these
    Distribution deals.What makes it so difficult for the market is that there is
    no "upfront" premium price consideration..only Royalty based payment.So,
    without any disclosure of the Royalty Agreement..there is no way of knowing
    whether,in this case, Omni has even negotiated a favourable deal..?

    As this is a quality well researched "patented" product..there has to be a "lump sum"
    premium attached to buying into the technology etc...just like any other business
    when an investor buys in..otherwise there really no definitive "value" recognition in
    terms of" market value" of Distribution Right Agreement...similar in someways
    to industry Leasehold Going Concern businesses..valuation criteria

    On current UK non disclosure of details etc for above reasons,..hard to see much interest in CR

    Logically, an upfront payment in addition to Royalties would create some market
    confidence in strength of "brand" as well as perhaps eliminate need for ongoing CR"S
    until Royalty payments are established...

    Cheers

    Cheers
 
watchlist Created with Sketch. Add EVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.